MedTrace Logo

The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers

NCT05910541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-06-18

No results posted yet for this study

Summary

The goal of this clinical trial is to determine the efficacy of multisession mindful breathing in reducing symptoms among patients with advanced cancer. Adult patients with advanced cancer will be assessed using Edmonton Symptom Assessment System (ESAS) scoring system. Patients who scored ≥4 in at least two or more components in ESAS will be recruited and randomly assigned to either 4 daily-session of 30-minute mindful breathing and standard care or standard care alone.

Conditions

Interventions

BEHAVIORAL

Mindful breathing

30 minutes of mindful breathing session for 4 consecutive days, guided by investigators in addition to standard care.

OTHER

Standard care (control)

Standard care such as pain control, oxygen supplement.

Sponsors & Collaborators

  • University of Malaya

    collaborator OTHER

  • University Malaysia Sarawak

    lead OTHER

Principal Investigators

  • Diana Leh Ching Ng, MD · University Malaysia Sarawak

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-02
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910541 on ClinicalTrials.gov